Replies to post #210071 on Biotech Values

[genisi]

FDA’s acceptance of the Durvalumab BLA on 12/9/16 was indeed a big deal for AZN

Their first BLA.
When and if MYSTIC trial is successful, they can file based on at
least one approved drug.